OFA in Thoracic Surgery
Status
Conditions
Treatments
Details and patient eligibility
About
to investigate the efficacy and safety of opioid-free anesthesia for non-small-cell lung cancer resection and its underlying clinical value
Full description
Opioids used to have its irreplaceable role in standard opioid-based anesthesia, yet with the help of hypnotics, local anesthetics, anti-inflammatory drugs, α-2 agonists and epidural techniques, opioid-free anesthesia (OFA) has been proved to be safe and feasible for non-cardiac major surgeries. Opioid-sparing anesthesia (OSA) is encouraged by the needs of enhanced recovery and recommended by the latest guidelines for anesthesia of lung surgery. According to previous studies, both opioid-sparing and opioid-free anesthesia would reduce the incidence of opioid-related adverse events and speed up the postoperative recovery to some extent, yet no studies ever are dedicated to compare these two different techniques.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- going through thoracoscopic lung surgery including lobectomy, segmentectomy, single or multiple wedge resection, and two of the above procedures combined;
- able to complete the pain scoring face-to-face;
- no cognitive dysfunction or history of anesthetic drug allergy;
- ASA grade I-II
Exclusion criteria
-psychological disorders
Trial design
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Central trial contact
SHUWEI WANG
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal